These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7904978

  • 1. Growth hormone, insulin-like growth factor-1 and insulin resistance in cirrhosis.
    Shmueli E, Stewart M, Alberti KG, Record CO.
    Hepatology; 1994 Feb; 19(2):322-8. PubMed ID: 7904978
    [Abstract] [Full Text] [Related]

  • 2. Normal splanchnic but impaired peripheral insulin-stimulated glucose uptake in cirrhosis.
    Shmueli E, Walker M, Alberti G, Record CO.
    Hepatology; 1993 Jul; 18(1):86-95. PubMed ID: 8100799
    [Abstract] [Full Text] [Related]

  • 3. High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance.
    Shmueli E, Miell JP, Stewart M, Alberti KG, Record CO.
    Hepatology; 1996 Jul; 24(1):127-33. PubMed ID: 8707251
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Insulin sensitivity and body composition in cirrhosis: changes after TIPS.
    Holland-Fischer P, Nielsen MF, Vilstrup H, Tønner-Nielsen D, Mengel A, Schmitz O, Grønbaek H.
    Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G486-93. PubMed ID: 20489042
    [Abstract] [Full Text] [Related]

  • 8. Octreotide treatment does not improve impaired glucose uptake in cirrhosis.
    Shmueli E, Orskov H, Alberti KG, Record CO.
    Horm Metab Res; 1993 Jun; 25(6):317-20. PubMed ID: 8344648
    [Abstract] [Full Text] [Related]

  • 9. Characteristics of insulin resistance in Turner syndrome.
    Stoppoloni G, Prisco F, Alfano C, Iafusco D, Marrazzo G, Paolisso G.
    Diabete Metab; 1990 Jun; 16(4):267-71. PubMed ID: 1979950
    [Abstract] [Full Text] [Related]

  • 10. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.
    Tietge UJ, Selberg O, Kreter A, Bahr MJ, Pirlich M, Burchert W, Müller MJ, Manns MP, Böker KH.
    Liver Transpl; 2004 Aug; 10(8):1030-40. PubMed ID: 15390330
    [Abstract] [Full Text] [Related]

  • 11. Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans.
    Hussain MA, Schmitz O, Mengel A, Keller A, Christiansen JS, Zapf J, Froesch ER.
    J Clin Invest; 1993 Nov; 92(5):2249-56. PubMed ID: 8227340
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
    Laager R, Ninnis R, Keller U.
    J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
    [Abstract] [Full Text] [Related]

  • 13. Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm.
    Møller N, Bagger JP, Schmitz O, Jørgensen JO, Ovesen P, Møller J, Alberti KG, Orskov H.
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1789-93. PubMed ID: 7775624
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
    Kruszynska YT, Olefsky JM, Frias JP.
    Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.
    Hussain MA, Schmitz O, Mengel A, Glatz Y, Christiansen JS, Zapf J, Froesch ER.
    J Clin Invest; 1994 Sep; 94(3):1126-33. PubMed ID: 8083353
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone and carbohydrate intolerance in cirrhosis.
    Shankar TP, Solomon SS, Duckworth WC, Jerkins T, Iyer RS, Bobal MA.
    Horm Metab Res; 1988 Sep; 20(9):579-83. PubMed ID: 3058569
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Normalisation of insulin-like growth factor-I does not improve insulin action in cirrhosis.
    Nielsen MF, Aagaard NK, Grøfte T, Frystyk J, Greisen J, Christiansen JS, Holland-Fischer P, Vilstrup H.
    Liver Int; 2011 Nov; 31(10):1511-8. PubMed ID: 21967317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.